MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
2.860
-0.130
-4.35%
Closed 16:00 07/26 EDT
OPEN
2.920
PREV CLOSE
2.990
HIGH
2.970
LOW
2.801
VOLUME
12.64K
TURNOVER
0
52 WEEK HIGH
5.25
52 WEEK LOW
1.490
MARKET CAP
27.07M
P/E (TTM)
-1.0176
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TRIB last week (0715-0719)?
Weekly Report · 4d ago
Veterans Affairs Awards $4M Contract To Biopool US For Cost-Per-Test Services
Benzinga · 07/15 18:13
On July 12, 2024, Trinity Biotech Entered Into An ATM Offering Agreement With Craig-Hallum Capital Group, Pursuant To Which May Sell Up To $5.5M Of Its ADSs, Each ADS Representing 20 Of The Company's A Ordinary Shares (Co Will Also Pay Craig-Hallum A Commission Equal To 3% Of The Gross Sales Price Of ADSs)
Trinity Biotech plc entered into an At the Market Offering Agreement with Craig-Hallum Capital Group LLC on July 12, 2024. The Company may sell up to $5,500,000 of its American Depositary Shares. The company will pay Craig- hallum a commission equal to 3.0% of the gross sales price of the ADSs.
Benzinga · 07/15 15:21
Weekly Report: what happened at TRIB last week (0708-0712)?
Weekly Report · 07/15 09:26
Trinity Biotech Unveils New Share Offering Plan
TipRanks · 07/12 21:28
BRIEF-Trinity Biotech Says Entered Into An At Market Offering Agreement With Craig-Hallum Capital Group
Trinity Biotech Says Entered Into An At Market Offering Agreement With Craig-Hallum Capital Group. Company may sell up to $5.5 million of its American shares. Trinity Biotech says it has entered into the agreement with Craig- Hallum Capital group.
Reuters · 07/12 21:27
Executive reshuffles: ChargePoint, Tupperware and ADM in focus
Executive reshuffles: ChargePoint, Tupperware and ADM in focus. Several Wall Street executives stepped up for new roles as part of leadership reshuffling. Some companies such as ChargePoint and ADm added new positions to steer growth prospects to new positions.
Seeking Alpha · 07/12 16:15
Trinity Biotech Welcomes New CFO
TipRanks · 07/11 11:18
More
About TRIB
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Webull offers Trinity Biotech plc (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.